TWiV 872: COVID-19 clinical update #104 with Dr. Daniel Griffin
About this episode
In COVID-19 clinical update #104, Daniel Griffin reviews effectiveness of mRNA vaccines among children, number of children affected by disease, accuracy of rapid antigen tests, CDC guidance for prevention strategies, monoclonal antibody effectiveness, predicting progression to severe respiratory failure from pneumonia, risk of long COVID after two vaccine doses, and peripheral neuropathy in long COVID.
Subscribe (free): Apple Podcasts, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode
- Vaccine effectiveness 5-11 year olds (medRxiv)
- Vaccine effectiveness vs ED and UCE 5-12 year olds (medRxiv)
- Children affected by COVID (Lancet)
- Accuracy of rapid antigen tests (medRxiv)
- COVID community levels (CDC)
- Therapeutics guidelines (WHO)
- Mortality among SOT (Clin Inf Dis)
- Long COVID after two vaccine doses (medRxiv)
- Peripheral neuropathy in COVID patients (Neurology)
- Letters read on TWiV 872
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees
Send your questions for Dr. Griffin to [email protected]
Get every episode summarized
Each time This Week in Virology publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from This Week in Virology
TWiV 1309: Maybe they're all cancer vaccines
This Week in Virology
TWiV 1308: Clinical update with Dr. Daniel Griffin
This Week in Virology
TWiV 1307: My heart breaks for flu
This Week in Virology
TWiV 1306: Clinical update with Dr. Daniel Griffin
This Week in Virology